Equity
€13,940 from €128,623 in 2023
Equity fell by 89% in 2 years.
BC NEUROSOC
Lifetime
5 annual accounts with figures on one time axispeak €64,616 (2021)
€31,426▲ 448%
lowest -€11,236 (2024)
€11,940▲ €23,176
peak €128,623 (2023)
€13,940▼ 88.1%
€161,914▲ 195%
Board1 name since 2021
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Gross margin from €5,731 to €31,426Back to profit: €11,940Dividend €115,387Equity from €117,387 to €13,940Debts from €54,795 to €161,914
Key points
from the 2025 annual accountsTurnover
≈ €130,000 estimated
The micro format states no turnover.
Debts
€161,914 92% of the balance sheet
Financial debts 13%Suppliers 1%Taxes and wages 3%Other 84%
Of this, €141,509 falls due within a year.
Liquidity
0.92 was 4.63 in 2024
Short-term debts rose from €24,838 to €141,509.
Filings
5 annual accounts 3 late
The 2021 accounts came latest: 31 days after the end of the period.
Starting capital
€2,000 100 shares
Checked score
69
Healthy
Financially stronger than 34% of micro companies without a NACE code
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.3%
01-2025: 0.3%● unchanged vs 12-2024lowest value
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.4%▲ +0.1 percentage points vs 05-2025
07-2025: 0.4%● unchanged vs 06-2025
08-2025: 0.7%▲ +0.3 percentage points vs 07-2025
09-2025: 0.4%▼ -0.3 percentage points vs 08-2025
10-2025: 0.4%● unchanged vs 09-2025
11-2025: 0.4%● unchanged vs 10-2025
12-2025: 0.4%● unchanged vs 11-2025
01-2026: 0.4%● unchanged vs 12-2025
02-2026: 0.4%● unchanged vs 01-2026
03-2026: 0.4%● unchanged vs 02-2026
04-2026: 0.4%● unchanged vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.8%▲ +0.4 percentage points vs 07-2026highest value
09-2026: 0.6%▼ -0.2 percentage points vs 08-2026
10-2026: 0.6%● unchanged vs 09-2026
11-2026: 0.6%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Founded in 2021
Equity €13,940 (7.9% of total assets)
lowers risk
Size: total assets €175,854
Liquidity: current ratio 0.92, cash €97,204
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 21% of them on solvency, 52% on liquidity, 60% on profitability and 5% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 2,153 companies had the same profile as BC NEUROSOC has now. Each dot stands for 6 companies, two years later.
96.1%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
That fits the bankruptcy probability of BC NEUROSOC itself: 0.6% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,153 companies, not a prediction for BC NEUROSOC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.92 (4.63 in 2024), below 1. Short-term debt is 80.5% and cash 55.3% of total assets. 92.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 24 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 5 filingsDeviation from the deadline
2025
24 days late
2024
1 day early
2023
29 days late
2022
31 days early
2021
31 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 5 accounts on average 10 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 August (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- CAMBRON Blandine Emmanuelle Marie Françoise 100 sharesdeed of 18-01-2021
Recent changes
Incorporation
Founding capital of €2,000, 100 shares · Founder: CAMBRON Blandine Emmanuelle Marie Françoise · Appointment: CAMBRON Blandine Emmanuelle Marie Françoise (statutory director) · published on 18-01-2021 · Gazette deed
First establishment
Rue du Calvaire 38, Aiseau-Presles
Official details
Source: KBO- Status
- Active since 14-01-2021Normal situation
- Activity
- “L’exercice, en son nom et pour son compte, de la médecine, par le ou…” (deed in French)From the articles, 6 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.312.511.1776250 Aiseau-Presles, since 14-01-2021
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on BC NEUROSOC
BC NEUROSOC files the micro format. That format states no turnover. The gross margin fell from €64,616 in 2021 to €31,426 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BC NEUROSOC
- What is the company number of BC NEUROSOC?
- The company number of BC NEUROSOC is 0761.633.013. The VAT number is the same number with BE in front: BE 0761.633.013.
- Where is BC NEUROSOC based?
- The registered office is at Rue du Calvaire 38, 6250 Aiseau-Presles.Company details
- What is the legal form of BC NEUROSOC?
- BC NEUROSOC is a private limited company (BV).
- When was BC NEUROSOC founded?
- BC NEUROSOC was founded on 14-01-2021.
- Is BC NEUROSOC still active?
- Yes, BC NEUROSOC is an active enterprise in the KBO register.
- What is the turnover of BC NEUROSOC?
- The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €31,426 and 2,941 comparable companies of the same size. It probably lies between €76,000 and €230,000. It is a rough estimate.Financials
- Is BC NEUROSOC profitable?
- In financial year 2025, BC NEUROSOC made a profit of €11,940.
- Where can I find the annual accounts of BC NEUROSOC?
- BC NEUROSOC filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BC NEUROSOC due?
- BC NEUROSOC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.